Improved PFS in Advanced Kidney Cancer With Antiangiogenic Combination

By News Health
3 weeks Ago

(MedPage Today) — SAN FRANCISCO — Dual antiangiogenic therapy for previously treated kidney cancer significantly improved progression-free survival (PFS) versus a single drug, a large randomized trial showed.
Median PFS improved from 10.7…

Source link : https://www.medpagetoday.com/meetingcoverage/ascogu/120094

Author :

Publish date : 2026-02-28 15:00:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Inside the world’s first antimatter delivery service

Five questions that still need answering about the meningitis outbreak

Autism Panel Targets RFK Jr.'s Agenda

HPV Self-Testing in Primary Care Boosts Cervical Cancer Screening

It Was a Rough Match Day for Family Medicine, IMGs

Study Warns on High-Risk Group After Stool-Based Colon Cancer Screening